PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.

@article{Park2009PEGylatedPN,
  title={PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.},
  author={Jason Park and Peter M. Fong and Jing Lu and Kerry Russell and Carmen J Booth and W. Mark Saltzman and Tarek M. Fahmy},
  journal={Nanomedicine : nanotechnology, biology, and medicine},
  year={2009},
  volume={5 4},
  pages={410-8}
}
UNLABELLED We hypothesize that the efficacy of doxorubicin (DOX) can be maximized and dose-limiting cardiotoxicity minimized by controlled release from PEGylated nanoparticles. To test this hypothesis, a unique surface modification technique was used to create PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles encapsulating DOX. An avidin-biotin coupling system was used to control poly(ethylene glycol) conjugation to the surface of PLGA nanoparticles, of diameter approximately 130 nm… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 98 extracted citations

Effects of surfactants on the properties of PLGA nanoparticles.

Journal of biomedical materials research. Part A • 2012
View 4 Excerpts
Highly Influenced

PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.

Journal of controlled release : official journal of the Controlled Release Society • 2011
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…